These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28497561)

  • 1. On assessing bioequivalence and interchangeability between generics based on indirect comparisons.
    Zheng J; Chow SC; Yuan M
    Stat Med; 2017 Aug; 36(19):2978-2993. PubMed ID: 28497561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO.
    Gwaza L; Gordon J; Welink J; Potthast H; Hansson H; Stahl M; García-Arieta A
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1611-8. PubMed ID: 23011014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons.
    Gwaza L; Gordon J; Welink J; Potthast H; Leufkens H; Stahl M; García-Arieta A
    Antivir Ther; 2017; 22(2):135-144. PubMed ID: 27646863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.
    Vezina HE; Henry K; Ravindran GD; Kurpad AV; Raj TD; Fox K; Weller D; Brundage RC; Cavert W; Balfour HH
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):131-6. PubMed ID: 16394842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons.
    Gwaza L; Gordon J; Potthast H; Welink J; Leufkens H; Stahl M; García-Arieta A
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1083-9. PubMed ID: 26105964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusted indirect treatment comparison of the bioavailability of WHO-prequalified first-line generic antituberculosis medicines.
    Gwaza L; Gordon J; Welink J; Potthast H; Leufkens H; Stahl M; García-Arieta A
    Clin Pharmacol Ther; 2014 Nov; 96(5):580-8. PubMed ID: 24987832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing bioequivalence and drug interchangeability.
    Chen M; Chow SC
    J Biopharm Stat; 2017; 27(2):272-281. PubMed ID: 27936343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interchangeability of generic anti-epileptic drugs: a quantitative analysis of topiramate and gabapentin.
    Maliepaard M; Banishki N; Gispen-de Wied CC; Teerenstra S; Elferink AJ
    Eur J Clin Pharmacol; 2011 Oct; 67(10):1007-16. PubMed ID: 21494766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.
    Hosseinipour MC; Corbett AH; Kanyama C; Mshali I; Phakati S; Rezk NL; van der Horst C; Kashuba AD
    AIDS; 2007 Jan; 21(1):59-64. PubMed ID: 17148968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioequivalence and generics of index drugs with narrow therapeutic margins].
    Le Corre P
    Presse Med; 2010 Feb; 39(2):169-76. PubMed ID: 19932591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interchangeability of generic drugs for subpopulations: Bioequivalence simulation from a nonparametric PK model of gabapentin generic drugs.
    Glerum PJ; Yamada WM; Neely MN; Burger DM; Maliepaard M; Neef C
    Br J Clin Pharmacol; 2024 Jul; 90(7):1576-1585. PubMed ID: 36482842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia.
    Pejčić Z; Vučićević K; García-Arieta A; Miljković B
    Br J Clin Pharmacol; 2019 Sep; 85(9):2059-2065. PubMed ID: 31140620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
    Dupont AG; Heller F
    Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
    Bialer M; Midha KK
    Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On safety margin for drug interchangeability.
    Zheng J; Chow SC; Song F
    J Biopharm Stat; 2017; 27(2):293-307. PubMed ID: 27911675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some thoughts on drug interchangeability.
    Chow SC; Song F; Chen M
    J Biopharm Stat; 2016; 26(1):178-86. PubMed ID: 26366703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison.
    Herranz M; Morales-Alcelay S; Corredera-Hernández MT; de la Torre-Alvarado JM; Blázquez-Pérez A; Suárez-Gea ML; Alvarez C; García-Arieta A
    Eur J Clin Pharmacol; 2013 May; 69(5):1157-62. PubMed ID: 23196824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
    Odi R; Franco V; Perucca E; Bialer M
    Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.